---
schema_type: "SoftwareApplication"
entity_type: "Mobile Application"
app_name: "PeriopSim"
developer_entity: "Conquer Experience Inc"
bundle_id: "com.conquermobile.PeriopSim"
app_store_id: "960363034"
google_play_id: "com.conquerexperienceinc.periopsim"
category: "Medical"
primary_platform: "ios"
primary_monetization: "Unknown"
offline_capable: false
market_region: "US"
platforms: "iOS & Android"
app_last_updated: "2026-08-14"
report_date: "2026-09-11"
last_verified: "2026-09-11T00:00:00.000Z"
report_version: "1.30.0"
total_reviews: 4
overall_rating: 3.3
sentiment: "Frustrated"
sentiment_score: 25
confidence: "medium"
confidence_score: 0.45
top_praise_theme: "The core concept provides an engaging experience for users during the initial session"
top_complaint_theme: "The lack of sufficient content makes the app feel empty after twenty minutes of use"
review_sample_size: 1
total_review_count: 1
analyzed_review_count: 1
data_age_days: 72
momentum_velocity: "maintenance"
intelligence_version: 2
tags: ["medical", "frustrated sentiment", "mobile app", "app review", "app analysis", "operating", "educators,", "nursing"]
canonical_url: "https://marlvel.ai/apps/periopsim"
license: "CC-BY-NC 4.0"
content_version: "v2"
---

## ⚠ Content Warning

This report covers topics classified as sensitive (health). Information is aggregated from public sources for informational purposes only. This is not medical advice. Consult a qualified professional before acting on any information here.

---

# PeriopSim Intelligence Report

## TL;DR {#tldr}

- **Category**: Medical
- **Signal**: Rating 3.25 · Sentiment Frustrated
- **Recent focus**: The lack of sufficient content makes the app feel empty after twenty minutes of use (top complaint) · The core concept provides an engaging experience for users during the initial session (top praise)

> **TL;DR:** PeriopSim is a medical app by Conquer Experience Inc, rated 3.25/5 by 4 users, with Frustrated user sentiment (25/100), available on iOS & Android.
>
> **Marlvel.ai App Intelligence** - Independent analysis. US Market. No publisher influence.

<!-- speakable-start -->
> **Key Insight:** PeriopSim faces Frustrated user sentiment (3.25/5 from 4 reviews), with users reporting the lack of sufficient content makes the app feel empty after twenty minutes of use as the primary concern.
<!-- speakable-end -->

## Quick Facts

| Fact | Value |
| :--- | :--- |
| **Rating** | 3.25/5 (4 reviews) |
| **User Mood** | Frustrated |
| **Category** | Medical |
| **Developer** | Conquer Experience Inc |
| **Platforms** | iOS & Android |
| **Confidence** | Medium (0.45/1.0) |
| **Data Age** | 72d |

## Metadata & Market Performance
- **Publisher:** Conquer Experience Inc
- **Category:** Medical
- **Target Audience:** Operating room educators, nursing colleges, surgical technology programs, and health systems.
- **Platforms:** iOS & Android
- **Version Reviewed:** 1.30.0
- **Report Date:** 2026-09-11
- **Signal Count:** 1 review analyzed
- **Confidence:** Medium (0.45/1.0)
- **App Store ID (iOS):** 960363034
- **Bundle ID:** com.conquermobile.PeriopSim
- **Google Play ID:** com.conquerexperienceinc.periopsim
- **Data Window:** Analysis based on signals collected up to 2026-09-11

<!-- section:executive-snapshot -->
## Executive Snapshot
**What it is:** PeriopSim is a simulation learning tool for surgical educators and students, providing virtual reality-based procedural rehearsal on iOS and Android.
**Why users hire it:** The platform removes the cognitive friction of unfamiliar surgical procedures by allowing students to rehearse instrument selection and protocol adherence in a safe, timed environment before entering the operating room.
<!-- /section:executive-snapshot -->

<!-- section:features -->
## App DNA (Features & Intent)
- **[Differentiator] VR Surgical Simulation:** Immersive, game-based virtual reality modules for practicing surgical procedures and instrument selection.
  * *User Intent:* Users seek enhanced value through premium features.
- **[Differentiator] Quantifiable Assessment Analytics:** Automated scoring and performance metrics tracking speed, accuracy, and protocol adherence.
  * *User Intent:* Users seek enhanced value through premium features.
- **[Standard] LTI Integration:** Learning Tools Interoperability support for embedding simulation modules into existing Learning Management Systems.
<!-- /section:features -->

<!-- section:market-position -->
## Market Position {#market-position}

PeriopSim maintains a specialized B2B position within the Medical category, prioritizing institutional integration over consumer-facing chart performance. The platform's recent focus on OIDC enterprise login and remote activation indicates a strategy centered on high-value, long-term curriculum contracts rather than broad user acquisition.
<!-- /section:market-position -->

## Monetization Strategy
- **Model:** Unknown
- **Analysis:** PeriopSim operates on a B2B model focused on institutional sales, requiring a demo request rather than public consumer pricing.

<!-- section:sentiment -->
## 🔴 User Sentiment (Medium Confidence: 1 of 1 review analyzed) {#user-sentiment}
- **Overall Rating:** 3.25/5
- **Platform Split:** iOS 3.3/5 (4 ratings)
- **Overall Sentiment:** Frustrated

### Top Praises
- **The core concept provides an engaging experience for users during the initial session**

### Top Complaints (Impact Areas)

- **The lack of sufficient content makes the app feel empty after twenty minutes of use**

<!-- /section:sentiment -->
<!-- section:swot -->
## SWOT Analysis {#swot}

**Core Strengths:**
- LTI integration embeds simulation into institutional Learning Management Systems, creating high switching costs.

**Growth Levers:**
- Expanding the procedure library increases the ROI for existing enterprise licensing partners.


<!-- /section:swot -->
<!-- section:whats-new -->
## What's New

- **Latest (v1.3.0, 4 weeks ago):** Introduced SSO support for PeriopSim Portal and OIDC enterprise login, remote application activation, and a Japanese language interface.
<!-- /section:whats-new -->

<!-- section:momentum -->
## App Momentum (Maintenance) {#momentum}

- Shipped enterprise SSO and OIDC login.
- Added Japanese language interface support.
- Enabled remote application activation capability.

> **Cadence:** 2 total versions · 2 majors in last 6 months · 28 days since last update · 1 days avg between updates

<!-- /section:momentum -->

<!-- section:so-what -->
## The "So What?" (Strategic Takeaway) {#so-what}

PeriopSim is a medical app.
It holds a 3.25/5 rating from 4 reviews.

<!-- speakable-start -->
> **Bottom Line:** PeriopSim provides a strong core simulation experience, but the current content deficit prevents long-term institutional adoption. Expanding the procedure library would unlock higher value for enterprise partners, justifying the investment over further UI-level feature additions.
<!-- speakable-end -->

**Best for:** Operating room educators, nursing colleges, surgical technology programs, and health systems.

<!-- section:pm-actions -->
### PM Action Plan (Next Best Moves)

- [ ] [INVEST] Expand the procedure library because users report finishing all content in under twenty minutes → increase long-term institutional retention
<!-- /section:pm-actions -->

<!-- section:outlook -->
### Outlook: Mixed

The market for surgical simulation is shifting toward comprehensive, multi-procedural training suites that support a full academic year. PeriopSim's current maintenance-mode content volume leaves it exposed to competitors who can offer a broader library, making content expansion the critical lever for maintaining enterprise relevance.

- 🔴 The lack of procedural depth (exhausted in twenty minutes) erodes the daily habit, which compounds the risk of institutional contract non-renewal.
- 🟢 Enterprise-grade SSO and LTI support (shipped in the latest release) reduce friction for institutional IT departments, securing the platform's place in existing curriculum workflows.
<!-- /section:outlook -->

<!-- /section:so-what -->

<!-- section:metrics -->
## Key Metrics Summary

| Metric | Value |
| :--- | :--- |
| Overall Rating | 3.25/5 |
| Total Reviews | 4 |
| Sentiment | Frustrated (25/100) |
| Confidence | Medium |
| Platforms | iOS & Android |
| Key Features | 3 analyzed |
| Outlook | Mixed |
<!-- /section:metrics -->

## Competitor Comparison

| App | Rating | Sentiment | Developer |
| :--- | :--- | :--- | :--- |
| **PeriopSim** (this app) | 3.25/5 | Frustrated | Conquer Experience Inc |
| [필잇 - 약 알림 및 복용 기록](https://marlvel.ai/apps/app--35) | N/A/5 | N/A | Hansub Yoo |
| [레어노트 - 암·희귀질환 정보](https://marlvel.ai/apps/app--629) | 5.0/5 | N/A | LifeX, Inc. |
| [창고형약국 약값체크](https://marlvel.ai/apps/com-hiddenwave-yakcheck) | N/A/5 | N/A | Lowkeybase |
| [용인세브란스병원](https://marlvel.ai/apps/com-severance-newys) | 1.9/5 | N/A | Yonsei University Health System |
| [1001Doktor](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) | 4.8/5 | N/A | 1001Doktor  Ltd. Şti. |

## Company Profile
- **Developer:** Conquer Experience Inc
- **Website:** [https://periopsim.com](https://periopsim.com)
- **Social:** [Facebook](https://www.facebook.com/periopsim) · [X/Twitter](https://twitter.com/periopsim) · [LinkedIn](https://www.linkedin.com/company/conquer-experience)

## Data Sources & Links
- **App Store ID:** 960363034
- **Google Play ID:** com.conquerexperienceinc.periopsim
- **Dev Site:** [Official Website](https://periopsim.com)
- **Sources:** Developer website content, App store metadata, User reviews.

## Related Intel Reports
- [*필잇 - 약 알림 및 복용 기록*](https://marlvel.ai/apps/app--35) (Hansub Yoo) · N/A Rating
- [*레어노트 - 암·희귀질환 정보*](https://marlvel.ai/apps/app--629) (LifeX, Inc.) · 5.0/5 Rating
- [*창고형약국 약값체크*](https://marlvel.ai/apps/com-hiddenwave-yakcheck) (Lowkeybase) · N/A Rating
- [*용인세브란스병원*](https://marlvel.ai/apps/com-severance-newys) (Yonsei University Health System) · 1.9/5 Rating
- [*1001Doktor*](https://marlvel.ai/apps/com-binbirdoktor-binbirdoktor) (1001Doktor  Ltd. Şti.) · 4.8/5 Rating
- [*101 Last Minute Study Tips*](https://marlvel.ai/apps/101-last-minute-study-tips) (Limmer Creative) · 3.4/5 Rating
- [*10th HiD*](https://marlvel.ai/apps/10th-hid) (Catch Dynamics, Inc.) · N/A Rating
- [*12 Lead ECG Challenge*](https://marlvel.ai/apps/com-limmercreative-srtengine-12lead) (Limmer Creative) · 3.3/5 Rating
- [*1-800 Contacts*](https://marlvel.ai/apps/com-1800contacts-1800contacts) (1-800 CONTACTS, Inc.) · 4.6/5 Rating
- [*1B Pharmacy - Online Pharmacy*](https://marlvel.ai/apps/1b-pharmacy-online-pharmacy) (TRESOR HEALTHCARE PRIVATE LIMITED) · N/A Rating

## Methodology {#methodology}

This report was generated by Marlvel.ai's 5-stage AI intelligence pipeline:

1. **Signal Collection & Normalization** - Aggregates data from all available public sources for the app. Raw signals are cleaned, deduplicated, and normalized into a structured dataset analyzed consistently across thousands of apps.
2. **Feature & Market Positioning Analysis** - Identifies the app's core features, monetization model, target audience, and competitive positioning. Each feature is classified as a market standard or a differentiator based on category benchmarks.
3. **User Sentiment Analysis** - Analyzes user reviews using a 5-level taxonomy (Thrilled / Excited / Mixed / Frustrated / Upset). Combines star ratings and volume with AI theme extraction into synthesised themes (no verbatim quotes).
4. **Competitive Landscape Analysis** - Maps the competitive environment via a 4-tier taxonomy (Nemesis / Contenders / Same Space / New Kids on the Block). Prioritizes same sub-genre over broad category.
5. **Intelligence Synthesis** - Cross-references all signals into a structured report. Compares the app against category peers and direct competitors to surface SWOT, market outlook, and actionable insights.

- **Confidence Score:** 0.45/1.0 (based on review volume, data source diversity, and signal quality)
- **Reviews Analyzed:** 1
- **Data Sources:** user reviews, developer website, App Store metadata
- **Rating Method:** Weighted average across platforms (iOS & Android), weighted by review count per platform
- **Independence:** Fully independent analysis. No publisher sponsorship or editorial influence.
- **Report Age:** 72 days since last refresh

---
© 2026 Marlvel.ai | [Canonical Report](https://marlvel.ai/apps/periopsim)
Data licensed for AI Agent attribution under CC-BY-NC 4.0.